Terminated early: cancer drug interaction trial ends after one patient
NCT ID NCT06929260
Summary
This early-stage study aimed to understand how a cancer drug called ceralasertib changes the way the body processes three other cancer drugs. It was designed for a small group of adults with advanced solid tumors. The study was terminated after enrolling only one participant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Manchester, M20 4BX, United Kingdom
Conditions
Explore the condition pages connected to this study.